Document is current
Any future updates will be listed below
-
Authors
Canosa, Antonio https://orcid.org/0000-0001-5876-4079
Callegaro, Stefano
Manera, Umberto
Vasta, Rosario
Cabras, Sara
Di Pede, Francesca
De Mattei, Filippo
Palumbo, Francesca
Iazzolino, Barbara
Dei Giudici, Anastasia
Matteoni, Enrico
Zocco, Grazia
Minerva, Emilio
Maccabeo, Alessandra
Pellegrino, Giorgio
Pascariu, Daniela
Grassano, Maurizio
Piombino, Pietro
Testa, Marcella
Polverari, Giulia
Fuda, Giuseppe
Merulla, Ilaria
Casale, Federico
Gallone, Salvatore
Moglia, Cristina
Calvo, Andrea
Pagani, Marco
Chiò, Adriano
-
Funding
Funding for this research was provided by:
Università degli Studi di Torino
- License Information
-
More Information
Article History
Received: 18 June 2025
Accepted: 26 November 2025
First Online: 11 December 2025
Declarations
:
: The study was approved by the ethical committee ‘Comitato Etico Interaziendale Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino.’ The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Participants signed a written informed consent. They did not receive any remuneration for participation. Data were anonymised according to the European regulations for the protection of privacy.
: Adriano Chiò serves on Scientific Advisory Boards or Speakers Bureaus for Mitsubishi Tanabe, Biogen, Roche, Denali Pharma, Cytokinetics, Lilly, Ferrer, Zambon Biotech, PCT Therapeutics, and Amylyx Pharmaceuticals. He serves as a member of the Data and Safety Monitoring Committee for ABScience, Corcept and Ely Lilly. He received a research grant from Biogen. Andrea Calvo received a research grant from Cytokinetics. The other authors report no competing interests.
